Countdown to Teladoc (TDOC) Q2 Earnings: Wall Street Forecasts for Key Metrics

Core Insights - The consensus EPS estimate for Teladoc for the upcoming quarter has remained unchanged over the last 30 days, indicating a collective reevaluation by analysts [1] Revenue Estimates - Analysts predict that 'Revenues by Segment- BetterHelp' will reach $273.85 million, reflecting a year-over-year decrease of -6.3% [3] - The 'Revenues by Segment- BetterHelp- Therapy Services' is expected to be $269.86 million, indicating a year-over-year change of -6.4% [4] - 'Revenue by Type- Access fees' is anticipated to be $564.53 million, showing a decline of -1.9% from the prior-year quarter [5] - 'Revenues by Segment- Teladoc Health Integrated Care' is projected to reach $374.76 million, representing a year-over-year increase of +4.1% [11] - 'Revenues by Segment- BetterHelp- Other Wellness Services' is estimated at $5.16 million, indicating a significant year-over-year increase of +26.8% [12] - The average prediction for 'Revenue by Type- Other' stands at $84.83 million, suggesting a year-over-year change of +10.5% [13] EBITDA Estimates - The consensus estimate for 'Adjusted EBITDA- Teladoc Health Integrated Care' is $50.25 million, compared to $37.97 million reported in the same quarter of the previous year [7] - The estimate for 'Adjusted EBITDA- BetterHelp' is $25.48 million, down from $34.19 million a year ago [14] Membership and Visits - Analysts expect 'U.S. Integrated Care Members' to reach 92.39 million, up from 85.9 million a year ago [6] - The estimated number of 'Visits' is projected to be 5,171,145, compared to 4,700,000 in the previous year [15] Stock Performance - Teladoc shares have shown a return of -4.2% over the past month, contrasting with the Zacks S&P 500 composite's -0.2% change, indicating underperformance [15]